These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 10703807)
1. Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Parkin JM; Murphy M; Anderson J; El-Gadi S; Forster G; Pinching AJ Lancet; 2000 Feb; 355(9205):722-3. PubMed ID: 10703807 [TBL] [Abstract][Full Text] [Related]
2. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227 [TBL] [Abstract][Full Text] [Related]
3. Toxicity of antiretroviral agents. Struble KA; Pratt RD; Gitterman SR Am J Med; 1997 May; 102(5B):65-7; discussion 68-9. PubMed ID: 9845500 [No Abstract] [Full Text] [Related]
5. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538 [TBL] [Abstract][Full Text] [Related]
6. Sequential cutaneous drug reactions to protease inhibitors in the context of occupational post-exposure prophylaxis. Woolley I; Tapley N; Korman TM AIDS; 2003 Jul; 17(11):1709. PubMed ID: 12853759 [No Abstract] [Full Text] [Related]
7. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy. Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823 [No Abstract] [Full Text] [Related]
8. Lipid abnormalities in a healthcare worker receiving HIV prophylaxis. Allan DA; Behrman AJ Int J STD AIDS; 2001 Aug; 12(8):532-4. PubMed ID: 11487394 [TBL] [Abstract][Full Text] [Related]
9. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection. Nerad JL; Kessler HA Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537 [TBL] [Abstract][Full Text] [Related]
11. Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group. Hurwitz JJ; Fine N; Rachlis AR Can J Ophthalmol; 1999 Jun; 34(4):195-203. PubMed ID: 10396655 [No Abstract] [Full Text] [Related]
12. Post-exposure prophylaxis for HIV infection: a clinical trial comparing lopinavir/ritonavir versus atazanavir each with zidovudine/lamivudine. Diaz-Brito V; León A; Knobel H; Peraire J; Domingo P; Clotet B; Dalmau D; Cruceta A; Arnaiz JA; Gatell JM; García F; Antivir Ther; 2012; 17(2):337-46. PubMed ID: 22293542 [TBL] [Abstract][Full Text] [Related]
14. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505 [TBL] [Abstract][Full Text] [Related]
15. Rash-associated severe neutropenia as a side-effect of indinavir in HIV postexposure prophylaxis. Albrecht D; Vieler T; Horst HA AIDS; 2002 Oct; 16(15):2098-9. PubMed ID: 12370516 [No Abstract] [Full Text] [Related]
16. [The management of the occupational exposures of health workers to HIV]. Escribano Hernández A Aten Primaria; 1997 Jun; 20(1):54-6. PubMed ID: 9303664 [No Abstract] [Full Text] [Related]
17. Side effects and tolerability of post-exposure prophylaxis with zidovudine, lamivudine, and lopinavir/ritonavir: a comparative study with HIV/AIDS patients. Cai J; Xiao J; Zhang Q Chin Med J (Engl); 2014; 127(14):2632-6. PubMed ID: 25043080 [TBL] [Abstract][Full Text] [Related]
18. A phase I/II study of the protease inhibitor indinavir in children with HIV infection. Mueller BU; Sleasman J; Nelson RP; Smith S; Deutsch PJ; Ju W; Steinberg SM; Balis FM; Jarosinski PF; Brouwers P; Mistry G; Winchell G; Zwerski S; Sei S; Wood LV; Zeichner S; Pizzo PA Pediatrics; 1998 Jul; 102(1 Pt 1):101-9. PubMed ID: 9651421 [TBL] [Abstract][Full Text] [Related]
19. First once-daily drug simplifies dosing, offers new options in HIV-1 treatment. AIDS Alert; 1998 Nov; 13(11):121-4. PubMed ID: 11365967 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral rounds. When success is a pain. Bartlett JG; del Rio C AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461 [No Abstract] [Full Text] [Related] [Next] [New Search]